Vigilare Wealth Management Gamida Cell Ltd. Transaction History

Vigilare Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$3.85 - $6.44 $38,500 - $64,400	-10,000 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$5.85 - $8.33 $11,700 - $16,660	-2,000 Reduced 16.67%	10,000 $64,000
Q1 2021 Apr 29, 2021	BUY	$7.8 - $12.43 $93,600 - $149,160	12,000 New	12,000 $97,000
Q4 2020 Jan 14, 2021	SELL	$4.07 - $11.0 $48,840 - $132,000	-12,000 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$3.93 - $4.59 $47,160 - $55,080	12,000 New	12,000 $50,000

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.